Form D — Beacon Biosignals, Inc.
0001765647-26-000001 · filed Apr 15, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Technology filings
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Reported offering amount
- $103,280,711
- Reported amount sold
- $103,280,711
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Beacon Biosignals, Inc.
- CIK
- 1765647
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 22 Boston Wharf Road
BOSTON, MA 02210 - Phone
- 401-225-5782
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jacob A. Donoghue, M.D., Ph.D. · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Jarrett Revels · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Caitlin Donovan · DirectorBoston, MA Find on LinkedIn ↗
-
Pavel Raifeld · DirectorBoston, MA Find on LinkedIn ↗
-
Naveen Rao · DirectorBoston, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗